Impact of Cognitive & Metacognitive Performance on Knowledge Learning When Conducting Therapeutic Education Programs
- Conditions
- SchizophreniaBipolar Disorder
- Interventions
- Other: QUESTIONNAIRES
- Registration Number
- NCT04590300
- Lead Sponsor
- Centre Hospitalier Charles Perrens, Bordeaux
- Brief Summary
People with schizophrenia and bipolar disorder display alterations in cognition and metacognition. These alterations may have an impact on learning during therapeutic education programs.
- Detailed Description
Patient Therapeutic Education (FTE) is defined as a practice to help patients to acquire or maintain the skills needed to best manage their lives with a chronic disease. FTE includes organized awareness, information, learning and psychological and social assistance about the disease, prescribed treatments, various treatments offered, as well as information on organization of the global health system, and health behaviours. Performed by health professionals trained in this practice, FTE is intended to help patients and their close relatives and to understand their pathology, their treatments, collaborate with health care teams, and maintain or improve their quality of life. It aims to produce a complementary therapeutic effect of other health care interventions
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 108
- Consent to participate in the study,
- Suffering from a chronic condition for which an therapeutic patient education (TEP) program is proposed.
- Mastering the French language.
- Be a beneficiary of health insurance
- Poor understanding of instructions that make it impossible to consent or assess
- Neurodegenerative disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Bipolar disorder QUESTIONNAIRES 1 questionnaire at the beginning of the study, before FTE program 1 questionnaire at the end of FTE Schizophrenia QUESTIONNAIRES 1 questionnaire at the beginning of the study, before FTE program 1 questionnaire at the end of FTE
- Primary Outcome Measures
Name Time Method Evaluation of metacognitive impairments on knowledge acquired through a therapeutic education program with Subjective Scale To Investigate Cognition in Schizophrenia (SSTICS) 1 year assess the impact of possible metacognitive impairments on knowledge acquired through a therapeutic education program Minimum value 21
Evaluation of cognitive impairments on knowledge acquired through a therapeutic education program with Montreal Cognitive Assessment (MoCA) 1 year assess the impact of possible cognitive impairments on knowledge acquired through a therapeutic education program Minimum value = 0 \& Maximum value = 30 Score \< 26 is considered as abnormal
- Secondary Outcome Measures
Name Time Method assess the impact of self esteem acquired through a therapeutic education program with Rosenberg scale 1 year assess the evolution in self-esteem following this program.
assess the impact of depressive symptomatology acquired through a therapeutic education program with Center for Epidemiologic Studies-Depression (CES-D) scale 1 year assess the evolution in depressive symptoms following this program.
assess the impact of level of anxiety, acquired through a therapeutic education program with State-Trait-Anxiety Inventory (Forme Y) (STAI-Y) questionnaire 1 year assess the evolution in level of anxiety following this program.
assess the impact of literacy on knowledge acquired through a therapeutic education program with Rapid Estimate for Adult Literacy in Medicine (REALM-R) questionnaire 1 year assess the evolution in quality of life following this program.
Trial Locations
- Locations (1)
Centre Hospitalier CHARLES PERRENS
🇫🇷Bordeaux, Nouvelle Aquitaine, France